Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
BloFin Leads TOKEN2049 with Most Talked-About Exceptional Branding: Towering Whale Chess, Crane Booth & Full-House Whalefield Afterparty
-
ParaZero Secures Significant Purchase Order for Airobotics’ Autonomous Defense Drones, Strengthening Position in Booming Drone Defense Market
-
BloFin Leads TOKEN2049 with Most Talked-About Exceptional Branding: Towering Whale Chess, Crane Booth & Full-House Whalefield Afterparty
-
Brookfield Launches New Private Equity Evergreen Fund Structure in Canada
-
Middlefield Banc Corp. Reports 2025 Nine-Month Financial Results
-
DataVault AI and Wellgistics Health Announce Plans for PharmacyChain™ to Implement Manufacturer-to-Patient Blockchain-enabled Smart Contracts for the Prescription Drug Industry to Improve Efficiency
-
SCHMID Group secures Major Orders for AI Server PCB Production Equipment
-
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
-
Heidmar Maritime Holdings Corp. Update on Common Share Purchases by CEO
-
United Community Banks, Inc. Reports Third Quarter Earnings
-
Reckoner Capital Management Expands Alternative Credit Suite with Launch of BBB-B CLO ETF
-
Lantronix to Report Fiscal 2026 First Quarter Results on Nov. 5, 2025
-
Valour Inc. Launches Sky (SKY) ETP on Spotlight Stock Market, Reaching 100 Listed ETPs
-
ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology
-
FG Nexus Signs Non-Binding Letter of Intent to Sell Quebec Property
-
Digi Power X Appoints Wealth Management Leader Ajay Gupta to its Board of Directors
-
ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group
-
Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus at ACR Convergence 2025
-
FinWise Bancorp Announces Strategic Program Agreement with DreamFi, Inc. to Provide Financial Products that Empower Underbanked Communities to Build Financial Stability
-
Saia Announces Retirement of CIO Rohit Lal and Appointment of Successor Tarak Patel
-
POET Technologies Receives $5 Million Production Order for 800G Optical Engines
-
Appili Therapeutics to Attend BARDA Innovation Symposium 2025
-
Nurix Therapeutics Announces $250.0 Million Registered Offering of Common Stock
-
Gilat to Report Third Quarter 2025 Results on Wednesday, November 12th
-
Mutuum Finance (MUTM) Completes Phase 1 of Roadmap, Begins Development of DeFi Lending Protocol
-
Old National Bancorp Reports Third Quarter 2025 Results
-
Marex Group plc to acquire European fixed income market maker Valcourt SA
-
Atlas Warehouse Lending Company Recapitalized to Strengthen Investment-Grade Credit Profile and Expand Lending Capacity
-
Atea Pharmaceuticals to Host Virtual HCV KOL Panel Event on November 13, 2025
-
Presenting on Emerging Growth Conference 87 Day 2 on October 23; Register to live stream
-
Fidelity D & D Bancorp, Inc. Reports Third Quarter 2025 Financial Results
-
Mercury Awarded Contract To Develop Multi-Mission Subsystem for U.S. Military Programs
-
Electra Therapeutics Announces First Patients Dosed in the SURPASS Phase 2/3 Pivotal Study of ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
-
Stifel Reports Third Quarter 2025 Results
-
Troilus Announces Change of Auditor
-
Tonix Pharmaceuticals Announces First Patient Dosed in the Investigator-Initiated FOCUS Study of Tonix’s Intranasal Potentiated Oxytocin in AVP-D Conducted by Massachusetts General Hospital
-
Village Farms Introduces Industry-First, One-Way Aroma Valve in Cannabis Packaging
-
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
-
Electra Therapeutics Receives FDA Breakthrough Therapy and EMA Priority Medicines Designations for ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
-
Electra Therapeutics Announces $183 Million Series C Financing to Advance First-in-Class SIRP-Targeted Therapies for Immune Disorders and Cancer
-
T1 Energy Announces Preliminary Results for Third Quarter 2025
-
Curanex Pharmaceuticals Inc. Engages Strategic Investor Relations to Enhance Investor Communications and Engagement
-
Mobix Labs Wins Multi-Year U.S. Navy Follow-On Contract as Company Accelerates Growth in Defense and High-Tech Markets
-
Winnebago Industries Reports Fourth Quarter and Full Year Fiscal 2025 Results
-
Troilus Announces Change of Auditor
-
Enthusiast Gaming Provides Update Regarding Annual General and Special Meeting of Shareholders
-
As Companies Clamor to Adopt AI, Culture and Trust Dictates Success, Says New “AI for All Index™” from UKG’s Great Place To Work
-
Axsome Therapeutics to Participate in Upcoming Investor Conferences
-
OTC Markets Group Welcomes Aviva PLC to OTCQX
-
Dorman’s Complex Electronic Solutions Portfolio Expands With OE FIX® EPS Rack for Ram Trucks
